Pregnancy-Related Mortality Surveillance — United States , 1991 – 1999
暂无分享,去创建一个
Jeani Chang | C. Berg | C. Syverson | Jeani Chang | J. Herndon | S. M. | D. M. | Cynthia J Berg | L. Flowers | D. Ph. | L. Elam‐Evans | K. Seed | Laurie D Elam-Evans | Joy Herndon | Lisa Flowers | Kristi A Seed | Carla J Syverson | S. M. | L. Elam-Evans | Laurie D Elam-Evans | Jeani Chang | C. J. Berg | D. M. | Joy Herndon | Lisa Flowers | Lisa Flowers
[1] D. Scholes,et al. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. , 1999, JAMA.
[2] R. Aitmhand,et al. Serotypes and Antimicrobial Susceptibility of Group B Streptococcus Isolated from Neonates in Casablanca , 2000, Scandinavian journal of infectious diseases.
[3] F. Barrett,et al. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. , 1973, The Journal of pediatrics.
[4] J. Siegel,et al. Prevention of Early‐Onset Group B Streptococcal Disease: Another Look at Single‐Dose Penicillin at Birth , 1996, Obstetrics and gynecology.
[5] K. Bremme,et al. Neonatal septicemia due to group B streptococci — Perinatal risk factors and outcome of subsequent pregnancies , 1988, Journal of perinatal medicine.
[6] The use of race in medical research. , 1992, JAMA.
[7] B. Stoll,et al. Management of asymptomatic, term gestation neonates born to mothers treated with intrapartum antibiotics. , 1990, The Pediatric infectious disease journal.
[8] R. Gibbs,et al. Internal Fetal Monitoring and Maternal Infection Following Cesarean Section: A Prospective Study , 1978, Obstetrics and gynecology.
[9] P. Bornick,et al. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. , 1999, American journal of obstetrics and gynecology.
[10] A. Wilkinson,et al. Prospective surveillance of neonatal meningitis. , 1993, Archives of disease in childhood.
[11] G. Mccracken. Group B streptococci: the new challenge in neonatal infections. , 1973, The Journal of pediatrics.
[12] D. Kasper,et al. Colonization with group B streptococci in girls under 16 years of age. , 1977, Pediatrics.
[13] Jane M. Deeley,et al. The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci , 1983, British journal of obstetrics and gynaecology.
[14] R. Zimmerman,et al. Group B streptococcal neonatal and infant infections , 1973 .
[15] D. Kasper,et al. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. , 2000, The Journal of infectious diseases.
[16] G. Cutter,et al. Impact of maternal group B streptococcal screening on pediatric management in full-term newborns. , 1996, Archives of pediatrics & adolescent medicine.
[17] P. W. Bowman,et al. PHS Public Health Service , 1963 .
[18] D. Petitti,et al. The Influence of Intrapartum Antibiotics on the Clinical Spectrum of Early-Onset Group B Streptococcal Infection in Term Infants , 2000, Pediatrics.
[19] A. Schuchat,et al. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. , 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[20] C. Adair,et al. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. , 2001, The Journal of infectious diseases.
[21] P. Kelkar,et al. Cephalosporin allergy. , 2001, The New England journal of medicine.
[22] M. Kogan,et al. Racial differences in late prenatal care visits. , 1993, Journal of perinatology : official journal of the California Perinatal Association.
[23] E. Ayoub,et al. Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women. , 1977, The Journal of infectious diseases.
[24] M Boulvain,et al. Membrane sweeping for induction of labour. , 2005, The Cochrane database of systematic reviews.
[25] C. Berg,et al. Pregnancy-related mortality surveillance--United States, 1987-1990. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[26] Stella M. Yu. Healthy People 2010 , 1998, Maternal and Child Health Journal.
[27] K. Schoendorf,et al. Differences between black and white women in the use of prenatal care technologies. , 1994, American journal of obstetrics and gynecology.
[28] J. Kiely,et al. Trends in the Percentage of Women Who Received No Prenatal Care in the United States, 1980–1992: Contributions of the Demographic and Risk Effects , 1996, Obstetrics and gynecology.
[29] M. Avison,et al. Interscience Conference on Antimicrobial Agents and Chemotherapy , 2001 .
[30] M. Pass,et al. Puerperal and perinatal infections with group B streptococci. , 1982, American journal of obstetrics and gynecology.
[31] A. Schuchat,et al. Neonatal Group B Streptococcal Disease: How Infection Control Teams Can Contribute to Prevention Efforts , 2000, Infection Control & Hospital Epidemiology.
[32] D. Kasper,et al. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. , 1989, The New England journal of medicine.
[33] A. Mangeol. [Group B streptococcus]. , 1992, Soins. Gynecologie, obstetrique, puericulture, pediatrie.
[34] J. Miranda,et al. Timing of Intrapartum Ampicillin and Prevention of Vertical Transmission of Group B Streptococcus , 1998, Obstetrics and gynecology.
[35] A. Schuchat,et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. , 2000, The New England journal of medicine.
[36] A. Schuchat,et al. The Accuracy of Late Antenatal Screening Cultures in Predicting Genital Group B Streptococcal Colonization at Delivery , 1996, Obstetrics and gynecology.
[37] B. Sibai,et al. The accuracy and patient preference for self-collected group B Streptococcus cultures. , 1995, American journal of obstetrics and gynecology.
[38] I. Braveny,et al. Use of GBS Media for Rapid Detection of Group B Streptococci in Vaginal and Rectal Swabs from Women in Labor , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[39] M. Krohn,et al. Effect of a Screening–based Prevention Policy on Prevalence of Early‐Onset Group B Streptococcal Sepsis , 2000, Obstetrics and gynecology.
[40] C. Berg,et al. MATERNAL MORTALITY IN DEVELOPED COUNTRIES: NOT JUST A CONCERN OF THE PAST , 1995, Obstetrics and gynecology.
[41] Ronald N. Jones,et al. Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. , 2000, American journal of obstetrics and gynecology.
[42] Misclassification of maternal deaths--Washington State. , 1986, MMWR. Morbidity and mortality weekly report.
[43] C. Berg,et al. Pregnancy‐Related Mortality in the United States, 1987‐1990 , 1996, Obstetrics and gynecology.
[44] L. Schieve,et al. Low and very low birth weight in infants conceived with use of assisted reproductive technology. , 2002, The New England journal of medicine.
[45] K. O'Brien,et al. Integrated Monitoring of a New Group B Streptococcal Disease Prevention Program and Other Perinatal Infections , 2002, Maternal and Child Health Journal.
[46] E. Main,et al. Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols. , 2000, American journal of obstetrics and gynecology.
[47] L. Cabero,et al. Evaluation of the Granada Agar Plate for Detection of Vaginal and Rectal Group B Streptococci in Pregnant Women , 1999, Journal of Clinical Microbiology.
[48] J. Kriebs. Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. , 1998, Journal of nurse-midwifery.
[49] T. Asrat,et al. Potential consequences of widespread antepartal use of ampicillin. , 1998, American journal of obstetrics and gynecology.
[50] J. Troendle,et al. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. , 2001, The Journal of infectious diseases.
[51] M. Klebanoff,et al. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. , 1991, Obstetrics and gynecology.
[52] C. Berg,et al. Strategies to reduce pregnancy-related deaths; from identification and review to action , 2001 .
[53] Laurie F. Beck,et al. Prevalence of selected maternal behaviors and experiences, Pregnancy Risk Assessment Monitoring System (PRAMS), 1999. , 2002, Morbidity and mortality weekly report. Surveillance summaries.
[54] A. Schuchat,et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. , 1990, The Journal of infectious diseases.
[55] D. Kasper,et al. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. , 1976, The New England journal of medicine.
[56] D. Kasper,et al. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. , 1981, Pediatrics.
[57] L. Schieve,et al. Linking Birth and Infant Death Records With Assisted Reproductive Technology Data: Massachusetts, 1997–1998 , 2006, Maternal and Child Health Journal.
[58] R. Gibbs,et al. Logistic Regression Analysis of Risk Factors for Intra-Amniotic Infection , 1989, Obstetrics and gynecology.
[59] M. Amstey,et al. Compliance with the Centers for Disease Control and Prevention antenatal culture protocol for preventing group B streptococcal neonatal sepsis. , 1998, American journal of obstetrics and gynecology.
[60] C. Berg,et al. The check box: determining pregnancy status to improve maternal mortality surveillance. , 2000, American journal of preventive medicine.
[61] B. Fox. Delayed-onset postpartum meningitis due to group B streptococcus. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] Y. Gielchinsky,et al. Postpartum maternal group B streptococcal meningitis , 2005, Acta obstetricia et gynecologica Scandinavica.
[63] C. Strom,et al. Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis. , 1999, Infectious diseases in obstetrics and gynecology.
[64] A. Schuchat,et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. , 2002, The New England journal of medicine.
[65] M. Ismail,et al. Cervical ripening with prostaglandin gel and hygroscopic dilators. , 1998, Infectious diseases in obstetrics and gynecology.
[66] J. N. Martin,et al. Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. , 1999, American journal of obstetrics and gynecology.
[67] H. Atrash,et al. Is race a risk factor or a risk marker for preterm delivery? , 1993, Ethnicity & disease.
[68] J. Gould,et al. Antimicrobial Prevention of Early-onset Group B Streptococcal Sepsis: Estimates of Risk Reduction Based on a Critical Literature Review , 1999, Pediatrics.
[69] L. Ayers,et al. Bloodstream Infections in a Neonatal Intensive-Care Unit: 12 Years' Experience With an Antibiotic Control Program , 1999, Infection Control & Hospital Epidemiology.
[70] N. F. Jacobs,et al. Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. , 1998, Archives of pediatrics & adolescent medicine.
[71] G. Escobar,et al. Preventing Neonatal Group B Streptococcal Disease: Cost-Effectiveness in a Health Maintenance Organization and the Impact of Delayed Hospital Discharge for Newborns Who Received Intrapartum Antibiotics , 1999, Pediatrics.
[72] J. Froggatt,et al. Characterization and control of intraamniotic infection in an urban teaching hospital. , 1996, American journal of obstetrics and gynecology.
[73] R. Heidel,et al. Healthy People 2000: national health promotion and disease prevention objectives (excerpts). US Public Health Service. , 1991, Journal of allied health.
[74] H. Lawson,et al. Maternal Mortality in the United States, 1979-1986 , 1990, Obstetrics and gynecology.
[75] A. Schuchat,et al. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. , 1994, Epidemiologic reviews.
[76] M. Morgan,et al. Antibiotic resistance patterns of group B streptococcus in antenatal genital cultures , 1999 .
[77] R. Platt,et al. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[78] J. Blomquist,et al. Anaphylaxis in labor secondary to prophylaxis against group B Streptococcus. A case report. , 1999, The Journal of reproductive medicine.
[79] A. Andreu,et al. Use of Granada Medium To Detect Group B Streptococcal Colonization in Pregnant Women , 1999, Journal of Clinical Microbiology.
[80] William Oh,et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants , 2003 .
[81] B. Sibai,et al. Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care. , 1995, American journal of obstetrics and gynecology.
[82] B. Frentzen,et al. Peripartum infection associated with vaginal group B streptococcal colonization , 1994, Obstetrics and Gynecology.
[83] T. Lieu,et al. Neonatal Group B Streptococcal Infection in a Managed Care Population , 1998, Obstetrics and gynecology.
[84] D. Kasper,et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. , 1999, The Journal of infectious diseases.
[85] K. Boyer,et al. Prevention of early‐onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis , 1986, The New England journal of medicine.
[86] E. Hodnett,et al. International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. , 1997, American journal of obstetrics and gynecology.
[87] D. Luthy,et al. Performance of a group B streptococcal prophylaxis protocol combining high-risk treatment and low-risk screening. , 2000, American journal of obstetrics and gynecology.
[88] D. Aron,et al. Reliability of Birth Certificate Data: A Multi-Hospital Comparison to Medical Records Information , 2002, Maternal and Child Health Journal.
[89] N. Svenningsen,et al. Obstetrical care in future pregnancies after fetal loss in group B streptococcal septicemia. A prevention program based on bacteriological and immunological follow-up. , 1981, European journal of obstetrics, gynecology, and reproductive biology.
[90] S. Garland,et al. Group B Streptococcus (GBS) and Neonatal Infections: The Case for Intrapartum Chemoprophylaxis , 1991, The Australian & New Zealand journal of obstetrics & gynaecology.
[91] R. Edelman,et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. , 1996, American journal of obstetrics and gynecology.
[92] B. Stoll,et al. Risk Factors and Opportunities for Prevention of Early-Onset Neonatal Sepsis: A Multicenter Case-Control Study , 1999, Pediatrics.
[93] G. Comstock,et al. False tuberculin test results. , 1975, Chest.
[94] Mort Rosenberg,et al. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th Edition. , 2003 .
[95] A. Forsgren,et al. Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. , 1985, Scandinavian journal of infectious diseases.
[96] K. Boyer,et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. , 1983, The Journal of infectious diseases.
[97] F. Barros,et al. Does reducing infant mortality depend on preventing low birthweight? An analysis of temporal trends in the Americas. , 2005, Paediatric and perinatal epidemiology.
[98] A. Spitzer,et al. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed? , 1995, Pediatrics.
[99] R. Matorras,et al. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. , 1993, European journal of obstetrics, gynecology, and reproductive biology.
[100] B. Frentzen,et al. Risk Factors for Neonatal Sepsis , 1996, Obstetrics and gynecology.
[101] K. Boyer,et al. Group B streptococcal infections. , 2002, Pediatrics in review.
[102] H. Dillon,et al. A prospective study of group B streptococcal bacteriuria in pregnancy. , 1981, American journal of obstetrics and gynecology.
[103] M. Moos,et al. Group B streptococci: results of a protocol of antepartum screening and intrapartum treatment. , 1994, American journal of obstetrics and gynecology.
[104] R. Berkowitz,et al. Pregnancy Outcome at Age 40 and Older , 1996, Obstetrics and gynecology.
[105] E. Hafner,et al. Group B streptococci during pregnancy: a comparison of two screening and treatment protocols. , 1998, American journal of obstetrics and gynecology.
[106] M. Kogan,et al. Racial disparities in reported prenatal care advice from health care providers. , 1994, American journal of public health.
[107] B. Lavin,et al. Antibiotic Cycling and Marketing Into the 21st Century: A Perspective From the Pharmaceutical Industry , 2000, Infection Control & Hospital Epidemiology.
[108] S. Jocums,et al. Monitoring maternal mortality using vital records linkage. , 1995, American journal of preventive medicine.
[109] A. Schuchat,et al. Prevention of perinatal group B streptococcal infection: current controversies. , 2000, Obstetrics and gynecology.
[110] D. Soper,et al. Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. , 2001, American journal of obstetrics and gynecology.
[111] C. Adair,et al. Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[112] G. Cutter,et al. Strategies for the Prevention of Early‐Onset Neonatal Group B Streptococcal Sepsis: A Decision Analysis , 1994, Obstetrics and gynecology.
[113] G. Cutter,et al. The Pediatric Costs of Strategies for Minimizing the Risk of Early‐Onset Group B Streptococcal Disease , 1997, Obstetrics and gynecology.
[114] A. Fattom,et al. Prevention of Systemic Infections Caused by Group B Streptococcus and Staphylococcus aureus by Multivalent Polysaccharide‐Protein Conjugate Vaccines , 1995, Annals of the New York Academy of Sciences.
[115] D. Kasper,et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. , 1996, The Journal of clinical investigation.
[116] C. Baker,et al. Antimicrobial Susceptibilities of Group B Streptococci Isolated between 1992 and 1996 from Patients with Bacteremia or Meningitis , 1998, Antimicrobial Agents and Chemotherapy.
[117] K. Boyer,et al. Strategies for chemoprophylaxis of GBS early-onset infections. , 1985, Antibiotics and chemotherapy.
[118] H. Rosenberg. Improving cause-of-death statistics. , 1989, American journal of public health.
[119] R. Hall,et al. Lumbar puncture in the evaluation of suspected neonatal sepsis. , 1980, The Journal of pediatrics.
[120] John M. Lachin,et al. Biostatistical Methods: The Assessment of Relative Risks , 2000 .
[121] P. Duff,et al. Maternal and neonatal infection rates with three different protocols for prevention of group B streptococcal disease. , 1999, American journal of obstetrics and gynecology.
[122] R. Faix,et al. Maternal and Transplacental Pharmacokinetics of Cefazolin , 2001, Obstetrics and gynecology.
[123] A. Schuchat,et al. Impact of a risk-based prevention policy on neonatal group B streptococcal disease. , 1998, American journal of obstetrics and gynecology.
[124] K. Boyer,et al. Prevention of early-onset neonatal group B streptococcal disease. , 1997, Pediatrics.
[125] A. Schuchat,et al. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group. , 1994, The Pediatric infectious disease journal.
[126] L. Svenson,et al. Delayed childbearing and its impact on population rate changes in lower birth weight, multiple birth, and preterm delivery. , 2002, Pediatrics.
[127] K. Berkowitz,et al. Antibiotic resistance patterns of group B streptococci in pregnant women , 1990, Journal of clinical microbiology.
[128] A. M.P.H.WillieJ.AndersonGeraldJonesPatsyA.HallDavidN. From the Centers for Disease Control and Prevention. Entry into prenatal care--United States, 1989-1997. , 2000, JAMA.
[129] Bruce F. Folck,et al. Neonatal Sepsis Workups in Infants ≥2000 Grams at Birth: A Population-Based Study , 2000, Pediatrics.
[130] K. Boyer,et al. Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. I. Epidemiologic Rationale , 1984 .
[131] S. Kenyon,et al. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial , 2001, The Lancet.
[132] A. Schuchat. Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.
[133] M. Hansell. Sociodemographic factors and the quality of prenatal care. , 1991, American journal of public health.
[134] M. Gaddis,et al. Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns. , 1994, Pediatrics.
[135] P. Duff,et al. Assessment Of Rapid Identification Tests For Genital Carriage Of Group B Streptococci , 1992, Obstetrics and gynecology.
[136] W. Pinover,et al. Group B streptococcal meningitis in a pregnant woman before the onset of labor. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[137] M. Kogan,et al. Comparing mothers' reports on the content of prenatal care received with recommended national guidelines for care. , 1994, Public health reports.
[138] D. Isaacs,et al. Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections. , 1999, The Pediatric infectious disease journal.
[139] R. Feigin,et al. Group B beta hemolytic streptococcal meningitis in infants. , 1973, The Journal of pediatrics.
[140] B. Sibai,et al. Antibiotic use in pregnancy and drug-resistant infant sepsis. , 1999, American journal of obstetrics and gynecology.
[141] J. Troendle,et al. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[142] W. Ledger,et al. Amniotic fluid analysis. Its role in maternal neonatal infection. , 1978, Obstetrics and gynecology.
[143] W. Chavkin,et al. Ascertainment of maternal deaths in New York City. , 1991, American journal of public health.
[144] A. Spitzer,et al. Eight-Year Outcome of Universal Screening and Intrapartum Antibiotics for Maternal Group B Streptococcal Carriers , 1998 .
[145] A. Schuchat,et al. Comparison of prevention strategies for neonatal group B streptococcal infection: A population‐based economic analysis , 1993, Journal of the American Medical Association (JAMA).
[146] A. Schuchat,et al. Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization. , 2001, American journal of obstetrics and gynecology.
[147] P. H. Roy,et al. Rapid detection of group B streptococci in pregnant women at delivery. , 2000, The New England journal of medicine.
[148] Pregnancy-related mortality--Georgia, 1990-1992. , 1995, MMWR. Morbidity and mortality weekly report.
[149] L. Harrison,et al. Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.
[150] P. Azimi,et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. , 2001, American journal of obstetrics and gynecology.
[151] H. Atrash,et al. Maternal and perinatal mortality , 1992, Current opinion in obstetrics & gynecology.
[152] K. O'Brien,et al. Early-onset neonatal sepsis in the era of group B streptococcal prevention. , 2001, Pediatrics.
[153] T. Dye,et al. Retrospective maternal mortality case ascertainment in West Virginia, 1985 to 1989. , 1992, American journal of obstetrics and gynecology.
[154] R. Faix,et al. Frequent Resistance of Clinical Group B Streptococci Isolates to Clindamycin and Erythromycin , 1998, Obstetrics and gynecology.
[155] C. Qualls,et al. Prevention of Group B Streptococcus Early-onset Neonatal Sepsis: Comparison of the Center for Disease Control and Prevention Screening-Based Protocol to a Risk-Based Protocol in Infants at Greater Than 37 Weeks' Gestation , 2000, Journal of Perinatology.